Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mee Young Kim

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Life Sciences|September 27, 2015
DJ-1 protects against undernutrition-induced atrophy through inhibition of the MAPK-ubiquitin ligase pathway in myoblastsJunghwan Kim, Kyung-Jong Won, Seung Hyo Jung, et al.
Journal of Physical Therapy Science|November 22, 2013
Differences in Rheobase and Chronaxie between the Paretic and Non-Paretic Sides of Hemiplegic Stroke Patients: a Pilot StudyWon-Deok Lee, Ju-Hyun Kim, Jeong-Uk Lee, et al.
International Journal of Molecular Sciences|March 13, 2024
Integrated Bioinformatics Analysis Identified ASNS and DDIT3 as the Therapeutic Target in Castrate-Resistant Prostate CancerAe Ryang Jung, Sun Shin, Mee Young Kim, et al.
Tissue Engineering. Part A|March 4, 2020
Stem Cell/Oxygen-Releasing Microparticle Enhances Erectile Function in a Cavernous Nerve Injury ModelAe Ryang Jung, Yong Hyun Park, Ga Eun Kim, et al.
Korean Journal of Family Medicine|June 30, 2012
Correlation between Frailty Level and Adverse Health-related Outcomes of Community-Dwelling Elderly, One Year Retrospective StudyEun Young Shim, Seung Hyun Ma, Sun Hyoung Hong, et al.
American Journal of Cancer Research|July 12, 2021
Niclosamide exerts anticancer effects through inhibition of the FOXM1-mediated DNA damage response in prostate cancerMee Young Kim, Ae Ryang Jung, Dongho Shin, et al.
International Journal of Molecular Sciences|November 27, 2025
Novel Therapeutic Strategy for Renal Cell Carcinoma: Niclosamide Enhances Sunitinib Efficacy via DNA Repair and Cell Cycle PathwaysAe Ryang Jung, Ga Eun Kim, Mee Young Kim, et al.
Journal of Cancer|February 6, 2019
High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancerMee Young Kim, Ae Ryang Jung, Ga Eun Kim, et al.
Journal of Cancer|November 28, 2019
GV1001 inhibits cell viability and induces apoptosis in castration-resistant prostate cancer cells through the AKT/NF-κB/VEGF pathwayYong Hyun Park, Ae Ryang Jung, Ga Eun Kim, et al.
Tissue Engineering. Part A|August 29, 2018
Therapeutic Effect of Controlled Release of Dual Growth Factor Using Heparin-Pluronic Hydrogel/Gelatin-Poly (Ethylene Glycol)-Tyramine Hydrogel System in a Rat Model of Cavernous Nerve InjuryAe Ryang Jung, Yong Hyun Park, Seung Hwan Jeon, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Life Sciences|September 27, 2015
DJ-1 protects against undernutrition-induced atrophy through inhibition of the MAPK-ubiquitin ligase pathway in myoblastsJunghwan Kim, Kyung-Jong Won, Seung Hyo Jung, et al.
Journal of Physical Therapy Science|November 22, 2013
Differences in Rheobase and Chronaxie between the Paretic and Non-Paretic Sides of Hemiplegic Stroke Patients: a Pilot StudyWon-Deok Lee, Ju-Hyun Kim, Jeong-Uk Lee, et al.
International Journal of Molecular Sciences|March 13, 2024
Integrated Bioinformatics Analysis Identified ASNS and DDIT3 as the Therapeutic Target in Castrate-Resistant Prostate CancerAe Ryang Jung, Sun Shin, Mee Young Kim, et al.
Tissue Engineering. Part A|March 4, 2020
Stem Cell/Oxygen-Releasing Microparticle Enhances Erectile Function in a Cavernous Nerve Injury ModelAe Ryang Jung, Yong Hyun Park, Ga Eun Kim, et al.
Korean Journal of Family Medicine|June 30, 2012
Correlation between Frailty Level and Adverse Health-related Outcomes of Community-Dwelling Elderly, One Year Retrospective StudyEun Young Shim, Seung Hyun Ma, Sun Hyoung Hong, et al.
American Journal of Cancer Research|July 12, 2021
Niclosamide exerts anticancer effects through inhibition of the FOXM1-mediated DNA damage response in prostate cancerMee Young Kim, Ae Ryang Jung, Dongho Shin, et al.
International Journal of Molecular Sciences|November 27, 2025
Novel Therapeutic Strategy for Renal Cell Carcinoma: Niclosamide Enhances Sunitinib Efficacy via DNA Repair and Cell Cycle PathwaysAe Ryang Jung, Ga Eun Kim, Mee Young Kim, et al.
Journal of Cancer|February 6, 2019
High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancerMee Young Kim, Ae Ryang Jung, Ga Eun Kim, et al.
Journal of Cancer|November 28, 2019
GV1001 inhibits cell viability and induces apoptosis in castration-resistant prostate cancer cells through the AKT/NF-κB/VEGF pathwayYong Hyun Park, Ae Ryang Jung, Ga Eun Kim, et al.
Tissue Engineering. Part A|August 29, 2018
Therapeutic Effect of Controlled Release of Dual Growth Factor Using Heparin-Pluronic Hydrogel/Gelatin-Poly (Ethylene Glycol)-Tyramine Hydrogel System in a Rat Model of Cavernous Nerve InjuryAe Ryang Jung, Yong Hyun Park, Seung Hwan Jeon, et al.
Pageof 7